Impact of KRAS alterations in localized pancreatic cancer (PC).

Authors

Aditya V. Shreenivas

Aditya Varnam Shreenivas

Medical College of Wisconsin, Milwaukee, WI

Aditya Varnam Shreenivas , Kaitlin Annunzio , Mandana Kamgar , Sakti Chakrabarti , James P. Thomas , Srivats Madhavan , Kulwinder Dua , Abdul H. Khan , William Adrian Hall , Beth Erickson , Kathleen K. Christians , Callisia Clarke , Douglas B. Evans , Susan Tsai , Aniko Szabo , Raul Urrutia , Michael T Zimmermann , Honey V Reddi , Ben George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Pancreatic Cancer

Track

Pancreatic Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 431)

DOI

10.1200/JCO.2021.39.3_suppl.431

Abstract #

431

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

<span>Mutation-site localized non-B DNA burden and survival heterogeneity in early-stage pancreatic cancer.</span>

Mutation-site localized non-B DNA burden and survival heterogeneity in early-stage pancreatic cancer.

First Author: Qi Xu

Poster

2020 Gastrointestinal Cancers Symposium

Impact of <i>CDKN2A/b</i> status in pancreatic cancer (PC).

Impact of CDKN2A/b status in pancreatic cancer (PC).

First Author: Kaitlin Annunzio

Poster

2014 Gastrointestinal Cancers Symposium

Clinicopathologic features of patients with KRAS wild-type pancreatic adenocarcinoma.

Clinicopathologic features of patients with KRAS wild-type pancreatic adenocarcinoma.

First Author: Mohamed E. Salem

Poster

2013 Gastrointestinal Cancers Symposium

Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases.

Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases.

First Author: Nancy Kemeny